Submit Deal

NOVALIX

HQ - Strasbourg

Summary

NovAliX is a drug discovery CRO supporting therapeutic programs from target identification to preclinical candidates using advanced chemistry, pharmacology, and biophysical techniques.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Denis Zeyer
CEO
Christophe Dubost
CFO
Stephan Jenn
Co-Founder

Sort

07 Aug 2024|France|Pharmaceuticals

Target: NOVALIX

Bidder: BRUKER CORPORATION

4 Service Providers

2 Target | 2 Bidder

60 Dealmakers

5 Target | 55 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy